Repairon Announces Completion of Dose-Finding Part of BioVAT-HF Phase I/II Trial in Advanced Heart Failure

Repairon together with the University Medical Center Göttingen and the University Medical Center Schleswig-Holstein, Campus Lübeck, as well as the German Center for Cardiovascular Research announced the completion of enrollment and follow-up of patients in the dose-finding cohort of the BioVAT-HF-DZHK20 Phase I/II trial.